Patent Interference News Today

IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.

U.S. courts will have a full docket of challenging IP cases throughout 2023. Andy Warhol Found. for Visual Arts, Inc. v. Goldsmith, Amgen Inc. v. Sanofi, Interactive Wearables, LLC v. Polar Electro Oy et al., VIP Prods. LLC v. Jack Daniel's Props., Nike, Inc. v. StockX LLC.

With the continuing advancements of cutting-edge technologies — such as genome editing (CRISPR) and Non-Fungible Tokens (NFTs) — U.S. courts will have a full docket of challenging IP...

Is the genus claim dead, or has its demise been greatly exaggerated? We may soon have the Supreme Court’s answer. On April 18, following eight years…

Companies have been exploring the potential to use combinations of various checkpoint inhibitors to enhance the treatment of patients with various…

The CRISPR-Cas9 gene editing system has revolutionized genetic engineering. Over the last decade, this technology has exploded at a breathtaking pace due to its simplicity, scalability, affordability and adaptability.

The CRISPR-Cas9 gene editing system has revolutionized genetic engineering. Over the last decade, this technology has exploded at a breathtaking pace…

In yet another round of the ever-expanding disputes surrounding CRISPR technology, the Patent Trial and Appeal Board PTAB recently denied priority to patentee SNIPR Technologies in its interference fight with Rockefeller University.

On October 1st, Senior Party ToolGen Inc. filed its Motion to Exclude certain evidence presented by Junior Party the Broad Institute, Harvard University, and MIT (collectively, "Broad")...

On May 28th, Junior Party the Broad Institute, Harvard University, and MIT (collectively, "Broad") filed its Substantive Preliminary Motion No. 1 in CRISPR Interference No. 106,126,...